Nuvectis Pharma
NVCT
NVCT
40 hedge funds and large institutions have $12.8M invested in Nuvectis Pharma in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
0.07% less ownership
Funds ownership: 8.86% → 8.79% (-0.07%)
Holders
40
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$207K | |
| 2 | +$118K | |
| 3 | +$99.1K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$98.1K |
| 5 |
State Street
Boston,
Massachusetts
|
+$91K |
Top Sellers
| 1 | -$214K | |
| 2 | -$190K | |
| 3 | -$124K | |
| 4 |
Morgan Stanley
New York
|
-$38K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$30.6K |